Latest AusBiotech News | Page 10

QIMR Berghofer grants and license agreement for potential vaccine
Recce Pharmaceuticals announces appointment of executive chairman
Framework released to facilitate university-industry partnerships
Starpharma wins recognition for development of Covid antiviral nasal spray
Rebranded AcuraBio acquired by major investors
AusBiotech 2022 programme launched
Monash University AI model could predict best epilepsy medicine
Optiscan Imaging submits 510 application to US FDA
Nominations open for AusBiotech Board
Alterity Therapeutics launches clinical trial in Europe
Prescient Therapeutics launches share purchase plan to raise $8 million
Proposed regulatory changes for clinical trials of medical devices
Long Covid study identifies novel blood markers as potential targets
Dimerix confirms CLARITY 2.0 Covid study concludes recruitment
Positions vacant on key TGA statutory advisory committees
CSL starts planning to submit new antibody treatment
Cyclopharm reports strong revenue growth for six months to June
Accelerating biotech’s future workforce needs
Microbio receives clearance to sell in vitro diagnostic test in UK
EpiAxis Therapeutics and Peptilogics announce new collaboration
Best practice resource for life sciences to be updated
Notice of AusBiotech’s AGM and forthcoming election 2022
Starpharma announces new research agreement for DEP drug delivery platform
First patient enrolled in new trial of NovoSorb SynPath treatment
Industry leaders to develop ESG framework
DImerix announces new patient family for DMX-700
Telix and UQ-led consortium awarded Australian Research Council grant
Life sciences directory to connect industry
Email re: ‘AusBiotech 2022 contact lists’
Pfizer raises offer for Australian digital health company
Radiopharm Theranostics announces new agreements with Lantheus and NanoMab
AusBiotech 2022 programme features top industry experts
Recruitment open for new study of lung disease
Lumos Diagnostics announces plan to close US facility
New study published demonstrating utility of PromarkerD test
Australia’s Cell and Gene Catalyst moves ahead
Genetic Signatures completes recruitment in pivotal clinical trial
Immuron provides update on FDA review of IND application
Nominations open to recognise sector leaders
Adherium wins US clearance for GSK inhaler users to connect to new platform
Patent filings increase in new intellectual property report
Amplia Therapeutics’ trial to be presented at major US conference
Australia’s first national biotechnology incubator announces round one funding
ACCC clears Pfizer acquisition of Australian digital health company
International consultation on medical device cybersecurity
Rhinomed announces Rhinoswab supply deal with SureScreen
Imugene appoints experienced executive as new chief financial officer
Cynata Therapeutics secures US patent for Use of Cymerus MSCs in Asthma